Alan Allgeier

    Education

• Ph.D., Chemistry, Northwestern University 
• M.S., Chemistry, Northwestern University 
• ​B.S., Chemistry, Case Western Reserve University

Professional Experience

The University of Kansas (2017 - Present)
Associate Professor: Chemical and Petroleum Engineering

DuPont (2011 - 2017)
Senior Principal Scientist
Corporate Center for Analytical Sciences: Technology leader for surface and particle science characterization.

Amgen, Inc.  (2004 - 2011)
Senior Research Chemist
Small Molecule Process Development Group: Technology leader for catalysis applied to pharmaceutical clinical manufacturing.

DuPont (1997 - 2004)
Senior Research Chemist: Heterogeneous catalysis and three-phase reactions
Postdoctoral Research Scientist (1997)

Honors

Russell Malz Award for Service to Catalysis, 2014. Organic Reactions Catalysis Society.

Amgen Green Chemistry Award, 2011. “A Novel, Green Process for AMG 423” – Amgen, Inc.

Sigma Xi Award, 1994 for excellence in graduate research – Northwestern University​

Research Summary

As an Associate Professor of Chemical Engineering, Dr. Alan Allgeier utilizes experiences from his twenty-year career in the chemical and pharmaceutical industries to envision and realize revolutionary technologies for the sustainable manufacture of chemicals and materials. His expertise in heterogeneous and homogeneous catalysis and reactor design have been instrumental in production of large scale (monomers for nylon and polyesters) and small scale (clinical-scale pharmaceuticals and specialty chemicals) products. Beyond sustainable manufacturing, Dr. Allgeier focuses on the characterization of porous materials including catalysts but also biomass, thermal insulation, solid formulations of pharmaceuticals and adsorbents. At the University of Kansas, he is building a research group around three themes:

1. Characterization of porous materials and colloidal systems with a multi-technique approach including novel applications of NMR relaxometry
2. Continuous flow processing applied to pharmaceuticals, with emphasis on enhancing mass transport across phase boundaries
3. Synthesis and characterization of heterogeneous catalysts with unique reactivity